Cancer and ageing
Human evidence and active trials are visible in this field
515 human-evidence records · 160 active trials · 560 visible funding records · 6,594 universities
Longevity Patent Family
Piperlongumine derivative with anti-tumor and anti-aging activity as well as preparation method and application of piperlongumine derivative
Source-linked patent metadata for Piperlongumine derivative with anti-tumor and anti-aging activity as well as preparation method and application of piperlongumine derivative, including priority, record stage and longevity-topic connections.
Patent-family snapshot
Application publication visible
Family grouping brings related publications for the same invention together, instead of counting every national filing as a separate technology.
- Representative publication
- CN121800766A
- Earliest priority
- December 28, 2025
- Latest publication
- April 7, 2026
- Family publications
- 1
- Patent offices
- 1
Patent-to-Evidence Translation Map
What is happening in the same scientific field?
These connections share a longevity topic with this patent record. They do not prove that the listed evidence, trials, funders, or universities validate, finance, own, or support this invention.
Organizations named in this family
Topics connected by metadata
Cancer and ageing88% metadata match
What this family cites
- Earlier patent references
- 0
- Scientific and other non-patent references
- 0
- Priority dates represented
- 1
References show which earlier documents the patent record points to. They do not validate the invention or prove that cited research supports its claims.
How the patent office classifies this invention
No patent classification is available in the retained record.
Verify in the original patent source →